Keyphrases
Multidrug-resistant Tuberculosis (MDR-TB)
100%
Health Anxiety
100%
Global Health
100%
Drug Resistance
33%
Risk Factors
16%
Poor Outcome
16%
Next-generation Sequencing
16%
Genetic Resistance
16%
Drug Regimen
16%
Preventive Treatment
16%
Human-to-human Transmission
16%
Clinical Application
16%
Effective Treatment
16%
Mycobacterium Tuberculosis (M. tb)
16%
Recent Advances
16%
Unsuccessful Treatment
16%
Mental Health
16%
Resistance Mechanisms
16%
Antimicrobial Resistance
16%
Resistance Acquisition
16%
Late Diagnosis
16%
Resistance Phenotypes
16%
Tuberculosis Diagnosis
16%
Cure Rate
16%
Treatment Therapy
16%
Risk Determinants
16%
Rapid Molecular Diagnostics
16%
Early Phase Clinical Trials
16%
Clinical Trial Data
16%
Health Considerations
16%
Person-centered Approach
16%
Attributable Deaths
16%
Drug Susceptibility Testing
16%
Mental Health Burden
16%
High-risk Contacts
16%
Medicine and Dentistry
Drug Resistant Tuberculosis
100%
Drug Resistance
33%
Mental Health
33%
Clinical Trial
16%
Diagnosis
16%
Side Effect
16%
Antibiotic Resistance
16%
Drug Sensitivity
16%
Mycobacterium Tuberculosis
16%
Prophylaxis
16%
Genetic Resistance
16%
Next Generation Sequencing
16%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Resistant Tuberculosis
100%
Drug Resistance
33%
Clinical Trial
16%
Side Effect
16%
Mycobacterium Tuberculosis
16%
Antimicrobial Resistance
16%
Genetic Resistance
16%
Antibiotic Resistance
16%